Therapeutic vaccination of chronic hepatitis B patients with ABX203 (NASVAC) to prevent relapse after stopping NUCs: contrasting timing rebound between tenofovir and entecavir
Wedemeyer, H, Hui, A.J, Sukeepaisarnjaroen, W, Tangkijvanich, P, Su, W.W, Nieto, G.E.G, Gineste, P, Nitcheu, J, Crabé, S, Stepien, S, Cornberg, M, Trépo, C
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article
760 A PHASE III CLINICAL TRIAL WITH A NASAL VACCINE CONTAINING BOTH HBsAg AND HBcAg IN PATIENTS WITH CHRONIC HEPATITIS B
Mahtab, M.A, Akbar, F, Uddin, H, Rahman, S, Rubido, J.C.A, Nieto, G.E.G, Onji, M, Mishiro, S
Published in Journal of hepatology (01.04.2013)
Published in Journal of hepatology (01.04.2013)
Get full text
Journal Article
LBP-518 - Therapeutic vaccination of chronic hepatitis B patients with ABX203 (NASVAC) to prevent relapse after stopping NUCs: contrasting timing rebound between tenofovir and entecavir
Wedemeyer, H., Hui, A.J., Sukeepaisarnjaroen, W., Tangkijvanich, P., Su, W.W., Nieto, G.E.G., Gineste, P., Nitcheu, J., Crabé, S., Stepien, S., Cornberg, M., Trépo, C.
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article